期刊名称：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Biochemical and Biophysical Research Communications is the premier international journal devoted to the very rapid dissemination (six weeks) of timely and significant experimental results in the diverse fields of biological research. Frequent publication (52 issues per year) ensures a steady stream of information. The development of the "Breakthroughs and Views" section brings the minireview format to the journal. In addition, the editors have expanded the journal's scope.
Research Areas now include:
Biochemistry
Biophysics
Cell Biology
Developmental Biology
Immunology
Molecular Biology
Neurobiology
Plant Biology
Proteomics
|
|
Instructions to Authors
Biochemical and Biophysical Research Communications (BBRC) is devoted to the rapid dissemination of timely and significant observations in the diverse fields of modern experimental biology. Articles submitted should be written to emphasize clearly the novel aspects of the information reported.
Submission of Manuscripts
Authors should submit their manuscripts electronically to one of the Editors listed on the inside front cover, not to the BBRC Editorial Office. Manuscripts submitted directly to the Editorial Office will be returned. Hard copies of manuscripts will not be accepted. The e-mail addresses and areas of interest for each Editor can be found at http://www.elsevier.com/inca/publications/misc/622790areas.htm. The preferred text format is .rtf, and the only acceptable formats for artwork are .tif, .eps, .ppt, and .jpg. Please submit the figures in one file and the text in another.
There are no submission fees or page charges. Because of the rapid review process of the journal, the Editors do not acknowledge receipt. Failure to follow these procedures will result in the manuscript's being returned to you.
Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published or is under consideration for publication elsewhere and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out. Manuscripts that do not meet the general criteria or standards for publication in BBRC will be immediately returned to the authors, without detailed review.
Any manuscript rejected by one Editor may not be resubmitted to a different Editor; any revised version should be sent to the original Editor.
Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright, see http://authors.elsevier.com). This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided after acceptance.
If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier Global Rights Department, P.O. Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com.
Breakthroughs and Views
This section includes minireviews, commentaries, and views on relevant subject matter, not simply short papers. Authors submitting a manuscript for this section should, in a cover letter, indicate that they are "submitting a manuscript for the Breakthroughs and Views section." Minireviews generally are invited; however, authors may inquire about potential interest in a minireview. Manuscripts for the Breakthroughs and Views section should be sent to William J. Lennarz (see list of Editors for e-mail address). Articles should not exceed 9 to 10 double-spaced, typewritten pages (including tables, figures, and references). One page of figures in articles in Breakthroughs and Views can be published in color, free of charge. The authors of minireviews may, if they wish, annotate a limited number of references. Two hypothetical examples follow:
[1] J.Y. Smith, S.S. Doe, A novel retinoid-response gene set in vascular smooth muscle cells, J. Biol. 280 (2000) 5-8. [A very concise review of recent findings.]
[2] J.Y. Black, R.J. Blue, Magnetic field exposure induces DNA degradation, Biol. Acta 120 (2001) 20-29. [The first study presenting detailed information on the enzyme activity.]
Preparation of Manuscript
Manuscripts must be written in clear, concise, grammatical English. Authors unfamiliar with English usage are encouraged to seek the help of English-speaking colleagues in preparing their manuscripts.
Authors in Japan kindly note that, upon request, Elsevier Japan will provide a list of people who can check and improve the English of an article before submission. Contact our Tokyo office: Elsevier K.K., Editorial Service, 1-9-15 Higashi Azabu, Minato-ku, Tokyo 106-0044, Japan; tel.: +81-3-5561-5032; fax: +81-3-5561-5045; e-mail: info@elsevier.co.jp.
Manuscripts should be double-spaced throughout, with a minimum of 1-inch margins. The length of the article should not exceed six printed journal pages, including all figures and tables (one page contains approximately 880 words, two or three figures or tables, or 34 references). For information on article length for Breakthroughs and Views, refer to the previous paragraph. Pages should be numbered consecutively and organized as follows:
The Title Page (p. 1) should contain an article title of less than 75 characters, the authors' names and complete affiliations, any footnotes to the title, and the name and address for manuscript correspondence (including e-mail address and fax numbers). Note that the title should not contain any nonstandard abbreviations. The corresponding author must confirm that the correspondence address in the manuscript agrees with the address in the cover letter.
The Abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in fewer than 150 words. After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included.
The Introduction should be as concise as possible, without subheadings.
Materials and methods should be sufficiently detailed to enable the experiments to be reproduced.
Results and Discussion may be combined and may be organized into subheadings.
Acknowledgments should be brief and should precede the references.
References to the literature should be cited by numbers in square brackets in the text and listed in numerical order with full article titles included. Use the most recent edition of the Chemical Abstracts Service Source Index for abbreviations of journal titles.
Reference to a journal publication: [1] A.G. Mueller, H.G. Joost, A. Schurmann, Mouse ARF-related protein 1: genomic organization and analysis of its promoter, Biochem. Biophys. Res. Commun. 292 (2002) 113-120.
Reference to a book: [2] W. Strunk Jr., E.B. White, The Elements of Style, third ed., Macmillan, New York, 1979.
Reference to a chapter in an edited book: [3] O.R. Mettam, L.B. Adams, How to prepare an electronic version of your article, in: E.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 1999, pp. 281-304.
Figures
Figures should be in a finished form suitable for publication. Number figures consecutively with Arabic numerals. Lettering on drawings should be professional quality or generated by high-resolution computer graphics and must be large enough to withstand appropriate reduction for publication. Artwork that is supplied electronically must be sent separately from the manuscript file in an acceptable format. Please visit our Web site at http://authors.elsevier.com/artwork for detailed instructions on preparing electronic artwork.
Color illustrations, to be submitted as electronic files, should have the figures sized close to the size expected in publication. If, together with your accepted article, you submit usable files of color figures, Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article.
Note: Because of technical complications that may arise in converting color figures to gray scale, for the printed version should you not opt for color in print, please submit in addition usable black-and-white files corresponding to all the color illustration files.
Tables
Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title typed directly above and with essential footnotes below.
Protein or Gene Databases
The Editors encourage the use of databases as repositories for detailed data on protein structure (e.g., X-ray crystallographic coordinates) and on DNA sequences and mapping assignments. Verification of submission and, when available, pertinent accession numbers should be provided with the manuscripts. Authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalized. (See example below.) This combination of letters and format will enable the typesetter to recognize the relevant texts as accession numbers and add the required links to GenBank sequences.
Example: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)."
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link. In the final version of the printed article, the accession number text will not appear bold or underlined. In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article.
Chemical or Biological Hazards
Chemical or biological hazards, if any, in carrying out the experiments described should be clearly noted in the Materials and Methods section. Any relevant safety precautions should be described. If an accepted code of practice has been followed, a reference to the relevant standards should be given.
Proofs
Corresponding authors will receive proofs by e-mail (PDF proofs). Because of the rapid publication schedule of BBRC, authors must check the proofs and return any corrections within 48 hours. Corrections should be restricted to typesetting errors, and all queries should be answered. Please proofread the manuscript carefully before initial submission to an Editor.
Editorial Board
|
Editors:
|
|
|
W. Baumeister, Max-Planck-Institut für Biochemie, Am Klopferspitz 18a, Martinsried bei München, Germany
|
|
|
E. Carafoli, Dipartimento de Chimica Biologica, Universita degli Studi de Padova, Italy
|
|
|
C.H. Chung, School of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul, Korea
|
|
|
A. Goffeau, Universite catholique de Louvain, FYSA: Unite de biochemie physiologique, Louvain-La-Neuve, Belgium
|
|
|
I.C. Gunsalus, Environmental Research Laboratory, Florida, USA
|
|
|
J.D. Jamieson, MD/PhD Program, Yale University School of Medicine, Connecticut, USA
|
|
|
C.B. Klee, M.D., Laboratory of Biochemistry, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 17, Room 6106C, 37 Convent Dr MSC 4255, Bethesda, MD 20892-4255
|
|
|
M.D. Lane, Department of Biological Chemistry, The Johns Hopkins University, Maryland, USA
|
|
|
W.J. Lennarz, Department of Biochemistry and Cell Biology, State University of New York at Stony Brook, New York, USA
|
|
|
M. Muramatsu, Research Center for Genomic Medicine, Saitama Medical School, Saitama-ken, Japan
|
|
|
Y-I. Nabeshima, Graduate School of Medicine, Kyoto University, Konoe-cho, Yoshida, Sakyo-ku, Building F, Kyoto-fu 606-8501, Japan
|
|
|
T. Omura, Hinosato, Munakata, Fukuoka, Japan
|
|
|
S. Orrenius, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
|
|
|
J. Pouyssegur, Centre Antoine Lacassagne, Nice, France
|
|
|
W.S. Reznikoff, Department of Biochemistry, University of Wisconsin at Madison, Wisconsin, USA
|
|
|
K. Takatsu, Institute of Medical Science, University of Tokyo, Tokyo, JAPAN
|
|
|
N. Taniguchi, Department of Biochemistry, Graduate School of Medicine, Osaka University Medical School, Osaka, Japan
|
|
|
R.J.P. Williams, University of Oxford, Inorganic Chemistry Laboratory, Oxford, United Kingdom
|
Tokyo office: Elsevier K.K., Editorial Service, 1-9-15 Higashi Azabu, Minato-ku, Tokyo 106-0044, Japan; tel.: +81-3-5561-5032; fax: +81-3-5561-5045; e-mail: info@elsevier.co.jp
|
